Home > PE Ratio > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of AKUMS DRUGS & PHARMACEUTICALS is 21.20.

Share Price ₹524.2Apr 28,2025
Market Cap ₹8,250.9 Cr
Earnings-TTM₹389.2 CrTTM-Consolidated Results
Price/Earnings21.20xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of AKUMS DRUGS & PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of AKUMS DRUGS & PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹8,250.9 Cr] as on Apr 28,2025

(/) Earnings [ ₹389.2 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 21.20x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for AKUMS DRUGS & PHARMACEUTICALS , the investors are currently willing to pay 21.20 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of AKUMS DRUGS & PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of AKUMS DRUGS & PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of AKUMS DRUGS & PHARMACEUTICALS


PE Ratio Performance Analysis for AKUMS DRUGS & PHARMACEUTICALS

- AKUMS DRUGS & PHARMACEUTICALS 's latest p/e ratio is 21.20x.

- AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.

- AKUMS DRUGS & PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 0x.

- AKUMS DRUGS & PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.


How does AKUMS DRUGS & PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
AKUMS DRUGS & PHARMACEUTICALS 389.1721.208,250.9
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0038.47441,910.0
DIVIS LABORATORIES LTD2,067.0077.42160,035.0
CIPLA LTD5,000.4325.11125,540.0
TORRENT PHARMACEUTICALS LTD1,862.0060.63112,894.0
DR REDDYS LABORATORIES LTD5,428.6018.44100,110.0
MANKIND PHARMA LTD2,050.7351.49105,587.0
ZYDUS LIFESCIENCES LTD4,591.8019.4189,137.2
LUPIN LTD2,892.1033.2896,241.1
AUROBINDO PHARMA LTD3,500.2520.6972,411.4
ABBOTT INDIA LTD1,334.4647.3763,214.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs AKUMS DRUGS & PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 18.44x
Max industry PE 77.42x
Median industry PE 33.28x
Average industry PE 37.59x



You may also like the below Video Courses